Delivery Order SPE2DB22D2007-SPE2DB25FJ5CK
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,662.25 to AmerisourceBergen Drug Corp for the supply of Mycophenolate 200 mg/mL suspension in 160 mL quantities. The contract, awarded on July 29, 2025, with a completion date of July 30, 2025, is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $2,743.68 to AmerisourceBergen Drug Corp for Mycophenolate 200 mg/ml suspension in 160 ml quantities. The contract, awarded July 22, 2025, with an ultimate completion date of July 23, 2025, represents a firm fixed-price delivery order with no set-aside designation. This award falls under a competitive procurement process, reflecting AmerisourceBergen's established capability to meet federal pharmaceutical supply requirements. The...
- The Defense Logistics Agency awarded a $4,296.65 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Mycophenolate 200 mg/ml suspension in a 160 ml quantity, with completion targeted for July 28, 2025. This firm fixed price contract represents a non-competitive set-aside award to the pharmaceutical distributor's corporate office, with performance to be executed in Conshohocken, Pennsylvania, where the company maintains its headquarters. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,576.30 in Mycophenolate 500 mg tablets (500-count units) on September 11, 2025, with an ultimate completion date of September 12, 2025. This is a firm fixed-price, non-set-aside contract with performance at the contractor's Conshohocken, Pennsylvania location. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a $2,896.01 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Mycophenolate 500 mg vials, with an ultimate completion date of September 12, 2025. This competitively awarded contract, issued without set-aside designation, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement running through December 2026....
- The Defense Logistics Agency awarded a $1,219.46 delivery order to AmerisourceBergen Drug Corp for Mycophenolate 500 mg tablets (100 count) on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed price, competitively awarded contract—which includes no set-aside designation—represents a child order under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The product will be performed at the contractor's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $1,215.32 delivery order to AmerisourceBergen Drug Corp for 500 capsules of Mycophenolate 250 mg, with a completion date of June 3, 2025. This non-set-aside, firm fixed-price delivery order was competitively awarded and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be performed from the contractor's Conshohocken, Pennsylvania location, where AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Mycophenolate 500 mg tablets (500-count units) valued at $5,782.51 with firm fixed pricing. This competitively awarded, non-set-aside contract is scheduled for completion by September 18, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger federal...
- The Defense Logistics Agency awarded a $5,369.44 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 160 milliliters of the pharmaceutical product Mycophenolate 200 mg/ml suspension. The place of performance for this single-day contract is Amerisourcebergen's facility located in Conshohocken, Pennsylvania. No major subcontractors or set aside designations were identified. This order is likely in support of the Defense Logistics Agency's stockpile of various...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a wholly-owned subsidiary of Amerisourcebergen Corporation, to provide 160 ml bottles of Mycophenolate 200 mg/ml suspension. The $3,561.92 contract has a completion date of February 26, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor for this delivery order. No set-aside designation was used. Amerisourcebergen Drug...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ5CKDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,022.37 to AmerisourceBergen Drug Corp for the supply of Mycophenolate 200 mg/mL suspension (160 mL) on September 18, 2025, with completion targeted for September 19, 2025. This is a firm fixed price, non-set-aside contract performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that enables comprehensive pharmaceutical and medical supply support to military healthcare systems globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, supplies critical medications and medical commodities to federal healthcare systems including the Defense Health Agency and U.S. Coast Guard. The company has demonstrated sustained capability in fulfilling federal medical procurement requirements through competitive awards, delivering a broad portfolio of pharmaceuticals across multiple therapeutic domains. This delivery order for Mycophenolate, an immunosuppressant medication, exemplifies the contractor's role in supporting military and defense healthcare operations through the DLA's pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 9/18/25 |